The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.00
Bid: 101.00
Ask: 103.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.98%)
Open: 102.00
High: 102.00
Low: 102.00
Prev. Close: 102.00
CNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

26 Mar 2015 07:00

RNS Number : 4918I
Concurrent Technologies PLC
26 March 2015
 



26 March 2015

Concurrent Technologies Plc

Results for the year ended 31 December 2014

 

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products, for critical applications in the defence, aerospace, transportation, telecommunications, scientific and industrial markets, announces results for the year to 31 December 2014.

 

Financial Highlights

 

· Turnover increased to £12.8m (2013: £11.9m)

· EBITDA increased to £3.0m (2013: £1.9m)

· Profit before Tax increased to £1.7m (2013: £0.5m)

· Cash in business plus deposits increased to £5.6m (2013: £4.9m)

· EPS increased to 2.28 pence (2013: 1.02 pence)

· Dividend increased by 2.86% to 1.80 pence per share for the year (2013: 1.75 pence)

 

Operational Highlights

 

· Success with sales associated with telecommunications base station test equipment using AMC architecture.

· Further growth in sales of products associated with scientific applications.

· Continued improvement in VPX™ architecture product sales mainly for defence applications.

· 4 new high performance processor boards, featuring the latest technology including 4th generation Intel®Core™ processors and new low power Intel® Atom™ processors.

· Relaxation of export regulations for most products containing encryption.

· Significant investment in new equipment for R&D and Manufacturing.

 

Michael Collins, Chairman, commented:

 

"Our products are used in a wide range of ever more sophisticated, high-reliability computer systems. Continual investment in R&D is critical to ensure a constant expansion of our range of advanced technology products and thereby enhance our competitive position. Our objective remains to design more innovative products for complex, high technology, low to medium volume and high margin applications, including versions for use in harsh environments. We will continue to develop the capabilities of these products with new and complementary software and firmware packages to provide high-speed data transfer, ease of integration and security. We will also continue to strengthen our engineering capabilities."

"The Group started 2015 with a strong order book and the improvement in the situation regarding export licence restrictions is also expected to benefit the Group's prospects throughout the year. We will continue to look for new opportunities and our diverse product range, coupled with investment in applying new technology, will enable us to take advantage of these opportunities in a variety of markets."

 

Annual General Meeting

 

The annual general meeting of Concurrent Technologies Plc will be held at the Company's offices at 4 Gilberd Court, Newcomen Way, Colchester, Essex, CO4 9WN, on 26 May 2015 at 2:30pm.

 

Enquiries:

 

Concurrent Technologies PlcGlen Fawcett, CEO

 

+44 (0)1206 752 626

Newgate (Financial PR)Tim Thompson

Robyn McConnachie

+44 (0)207 653 9850

Cenkos Securities plc (NOMAD)Neil McDonald

+44 (0)131 220 9771

Extracts from the Strategic Report

Review of Operations

Group revenue for 2014 was in line with expectations at £12.81m (2013: £11.86m). The overall growth of 8% was achieved despite performance continuing to be affected by the problem of having to apply for export licences for advanced technology products to emerging markets where we were anticipating sales growth. The exporting of products containing encryption, which encompassed many of the Company's products, was to a large extent, de-controlled in July 2014.This considerably simplified the exporting of the Company's products to its key markets outside of the EU and USA, and helped to improve our overall exports from 54% reported at the half year, to 60% over the full year (2013: 73%). Despite these difficulties, overall growth in exports to countries other than Europe and USA was 25%.

Another major success this year has been with sales associated with telecommunications test equipment, which has helped sales of our AMC architecture boards grow by 247%, and overall sales for telecommunications applications, by 71%.

Sales associated with scientific applications, especially for particle physics research projects, have also continued to grow, with a 42% increase during the year.

Investment in R&D increased from £2.35m in 2013 to £2.76m in 2014, of which £2.09m was capitalised (2013: £1.70m). The results for this year include a write down of our R&D design assets by £0.45m (2013: £0.84m), due in part to the continuing effects on possible future orders caused by the prior UK export licensing issues.

The Group EBITDA (measured as Operating Profit plus Depreciation and Amortisation) for 2014 was £3.00m (2013: £1.92m). The Group achieved a profit before tax for 2014 of £1.72m (2013: £0.45m). Earnings per share for the year were 2.28 pence (2013: 1.02 pence). The gross margin for the year was 51.2% compared with 50.6% for 2013.

Notwithstanding that the Company has again increased the dividend for 2014 and R&D spending, our cash balances at the year-end have improved to £5.62m (2013: £4.94m) and we have no borrowings.

Operational Highlights

Four new high performance embedded computers were released during the year, featuring the latest technology including 4th generation Intel® Core™ processors and new low power Intel®Atom™ processors. We have continued our investment in AMC architecture products, which has been rewarded in sales this year, and have also released further low power products in VME and CompactPCI® architectures. There has also been continuing growth in sales for our VPX™ architecture boards, which are mainly used in defence and surveillance related applications, including unmanned vehicles.

Additionally, together with our primary computer boards, we have released further accessory boards and storage modules to complement and give additional functionality to our main products. Another new important project is the development of a GPU accelerator board to augment the processing capability of our Intel® processor based AMC boards. GPU accelerated computing is a method of achieving very fast processing of "big data" applications and is particularly well suited to compute-intensive applications in areas such as scientific, engineering, financial, research, geographic and intelligence.

To assist with the design of environmentally superior products that can operate at extreme temperatures, elevated altitudes and at high shock and vibration levels, we have invested in our own shock and vibration test machine. On the manufacturing side, we have also invested in a powerful X-ray machine which can perform 3D scanning and sectional imaging to enable faster detection of faults inside components and PCBs. In addition, in order to alleviate capacity issues and speed up production throughput, in January 2015, we acquired an additional pick-and-place module for the very fast placement of components on boards.

Future Plans

Our products are used in a wide range of ever more sophisticated, high-reliability computer systems. Continual investment in R&D is critical to ensure a constant expansion of our range of advanced technology products and thereby enhance our competitive position. Our objective remains to design more innovative products for complex, high technology, low to medium volume and high margin applications, including versions for use in harsh environments. We will continue to develop the capabilities of these products with new and complementary software and firmware packages to provide high-speed data transfer, ease of integration and security. We will also continue to strengthen our engineering capabilities.

The Group started 2015 with a strong order book and the improvement in the situation regarding export licence restrictions is also expected to benefit the Group's prospects throughout the year. We will continue to look for new opportunities and our diverse product range, coupled with investment in applying new technology, will enable us to take advantage of these opportunities in a variety of markets.

 

 

Dividend

The Board has declared a second interim dividend of 1.15 pence per share (2013: 1.10 pence second interim dividend) which when added to the first interim dividend of 0.65 pence per share will make a total of 1.80 pence per share for the year (2013: 1.75 pence). This is an increase of 2.86% on dividends paid for 2013. The total cost of this second interim dividend will amount to £834,906. As in previous years, the Directors do not intend to recommend a final dividend.

Annual General Meeting

The annual general meeting of Concurrent Technologies Plc will be held at the Company's offices at 4 Gilberd Court, Newcomen Way, Colchester, Essex, CO4 9WN, on 26 May 2015 at 2:30pm.

 

All companies and product names are trademarks of their respective organisations.

 

Consolidated Statement of Comprehensive Income

Year to

Year to

31 December

31 December

2014

2013

CONTINUING OPERATIONS

£

£

Revenue

12,806,315

11,859,180

Cost of sales

6,247,748

5,857,094

Gross profit

6,558,567

6,002,086

Operating expenses

4,892,800

5,614,290

Group operating profit

1,665,767

387,796

Finance income

58,079

66,133

Profit before tax

1,723,846

453,929

Tax

76,148

(275,688)

Profit for the year

1,647,698

729,617

Other Comprehensive Income

Items that will be reclassified subsequently to profit or loss:

Exchange differences on translating foreign operations

90,539

(124,637)

Tax relating to components of other comprehensive income

-

-

Other Comprehensive Income for the year, net of tax

90,539

(124,637)

Total Comprehensive Income for the year

1,738,237

604,980

Profit for the period attributable to:

Equity holders of the parent

1,647,698

729,617

Total Comprehensive Income attributable to:

Equity holders of the parent

1,738,237

604,980

Earnings per share

Basic earnings per share

2.28p

1.02p

Diluted earnings per share

2.28p

1.01p

 

Consolidated Balance Sheet

As at

As at

31 December

31 December

2014

2013

£

£

ASSETS

Non-current assets

Property, plant and equipment

608,044

478,131

Intangible assets

6,018,931

5,467,503

Deferred tax assets

73,440

108,396

6,700,415

6,054,030

Current assets

Inventories

2,699,658

2,550,556

Trade and other receivables

2,790,426

2,874,354

Current tax assets

307,912

247,240

Other financial assets

-

2,602,689

Cash and cash equivalents

5,624,505

2,340,859

11,422,501

10,615,698

Total assets

18,122,916

16,669,728

LIABILITIES

Non-current liabilities

Deferred tax liabilities

1,279,852

1,164,267

Long term provisions

7,314

10,009

1,287,166

1,174,276

Current liabilities

Trade and other payables

2,500,524

1,931,110

Short term provisions

33,922

36,813

Current tax liabilities

665

-

2,535,111

1,967,923

Total liabilities

3,822,277

3,142,199

Net assets

14,300,639

13,527,529

EQUITY

Capital and reserves

Share capital

739,000

727,000

Share premium account

3,693,818

3,405,817

Capital redemption reserve

256,976

256,976

Cumulative translation reserve

15,723

(74,816)

Profit and loss account

9,595,122

9,212,552

Equity attributable to equity holders of the parent

14,300,639

13,527,529

Total equity

14,300,639

13,527,529

 

Consolidated Cash Flow Statement

Year to

Year to

31 December

31 December

2014

2013

£

£

Cash flows from operating activities

Profit before tax for the period

1,723,846

453,929

Adjustments for:

Finance income

(58,079)

(66,133)

Depreciation

178,059

169,259

Amortisation

1,160,940

1,363,530

Impairment loss

450,000

842,783

Share-based payment

6,279

(94,726)

Exchange differences

29,060

(74,551)

(Increase)/decrease in inventories

(149,102)

417,134

(Increase)/decrease in trade and other receivables

83,928

400,311

Increase/(decrease) in trade and other payables

563,828

426,431

Cash generated from operations

3,988,759

3,837,967

Tax (paid)/received

284

(61,654)

Net cash generated from operating activities

3,989,043

3,776,313

Cash flows from investing activities

Interest received

58,079

66,133

Cash released from/(placed) on Deposit

2,602,689

(602,689)

Purchases of property, plant and equipment (PPE)

(303,816)

(225,505)

Capitalisation of development costs and purchases of intangible assets

(2,161,809)

(1,726,312)

Net cash used in investing activities

195,143

(2,488,373)

Cash flows from financing activities

Equity dividends paid

(1,257,305)

(1,214,420)

Issue of Ordinary shares

300,001

-

Purchase of treasury shares

-

(16,625)

Net cash used in financing activities

(957,304)

(1,231,045)

Effects of exchange rate changes on cash and cash equivalents

56,764

(32,964)

Net increase/(decrease) in cash

3,283,646

23,931

Cash at beginning of period

2,340,859

2,316,928

Cash at the end of the period

5,624,505

2,340,859

 

Consolidated Statement of Changes in Equity

Capital

Cumulative

Profit

Share

Share

redemption

translation

and loss

Total

capital

premium

reserve

reserve

account

Equity

£

£

£

£

£

£

Balance at 1 January 2013

727,000

 3,405,817

256,976

49,821

9,862,012

14,301,626

Profit for the period

-

-

-

-

729,617

729,617

Exchange differences on translating foreign operations

-

-

-

(124,637)

-

(124,637)

Total comprehensive income for the period

-

-

-

(124,637)

729,617

604,980

Transactions with owners:

Share-based payment

-

-

-

-

(94,726)

(94,726)

Deferred tax on share based payment

-

-

-

-

(53,306)

(53,306)

Dividends paid

-

-

-

-

(1,214,420)

(1,214,420)

Purchase of treasury shares

-

-

-

-

(16,625)

(16,625)

Balance at 31 December 2013

727,000

 3,405,817

256,976

(74,816)

9,212,552

13,527,529

Profit for the period

-

-

-

-

1,647,698

1,647,698

Exchange differences on translating foreign operations

-

-

-

90,539

-

90,539

Total comprehensive income for the period

-

-

-

90,539

1,647,698

1,738,237

Transactions with owners:

Share-based payment

-

-

-

-

6,279

6,279

Deferred tax on share based payment

-

-

-

-

(14,102)

(14,102)

Dividends paid

-

-

-

-

(1257,305)

(1257,305)

Issue of Ordinary shares

12,000

288,001

-

-

-

300,001

Balance at 31 December 2014

739,000

3,693,818

256,976

15,723

9,595,122

14,300,639

 

NOTES

 

1. The Group financial statements consolidate those of the Company and its subsidiaries (together referred to as the 'Group'). The financial information set out in these preliminary results has been prepared in accordance with International Financial Reporting Standards ('IFRSs') as adopted by European Union. The accounting policies adopted in this results announcement have been consistently applied to all the years presented and are consistent with the policies used in the preparation of the statutory accounts for the period ended 31 December 2013. The consolidated financial information is presented in sterling (£), which is the company's functional and the Group's presentation currency.

 

2. The financial information set out above does not constitute the Group's statutory accounts for the years ended 31 December 2014 or 2013, but is derived from those accounts. Statutory accounts for 2013 have been delivered to the Registrar of Companies and those for 2014 will be delivered following the Annual General Meeting. The auditors have reported on those accounts; their reports were (i) unqualified, (ii) did not contain statements under section 498(2) or (3) of the Companies Act 2006 in respect of 2013 or 2014 and (iii) did not draw attention to any matters by way of emphasis.

 

3. The calculation of basic earnings per share is based on the weighted average number of Ordinary Shares in issue during 2014 of 72,278,298 (2013: 71,430,298) allowing for an adjustment made as a consequence of the Company having issued 1,200,000 Ordinary Shares on 08 April 2014 (2013: nil) and on the profit after tax for 2014 of £1,647,698 (2013: £729,617). The calculation of diluted earnings per share incorporates 11,992 Ordinary Shares (2013: 593,207) in respect of performance related employee share options. The profit after tax is the same as for basic earnings per share.

 

4. The annual general meeting of Concurrent Technologies Plc will be held at the Company's offices at 4 Gilberd Court, Newcomen Way, Colchester, Essex, CO4 9WN, on 26 May 2015 at 2:30pm.

 

Copies of the Annual Report will be sent to Shareholders and will also be available from the Company's Registered Office: 4, Gilberd Court, Newcomen Way, Colchester, Essex, CO4 9WN, UK, and on the Company's website: www.cct.co.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR EAPDSADASEFF
Date   Source Headline
1st May 20247:00 amRNSFinal results for the year ended 31 December 2023
24th Apr 20247:00 amRNSUS Contract Win and Notice of Results
9th Apr 20247:00 amRNSNew Product Announcement
5th Feb 20247:00 amRNSBoard Appointment
17th Jan 20247:00 amRNSTrading update
21st Dec 20237:00 amRNSKey VME Contract Win
19th Dec 20231:07 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSTrading Update
9th Nov 20237:00 amRNSNew Product Announcement
8th Nov 20237:00 amRNSChange of Nominated Adviser
7th Nov 20237:00 amRNSAppointment of New Auditors
2nd Nov 20237:00 amRNSHolding(s) in Company
24th Oct 20237:00 amRNSDirector/PDMR Dealing - Issue of Share Options
28th Sep 20237:00 amRNSNew Product Announcement
19th Sep 20237:00 amRNSInterim Results
6th Sep 20237:00 amRNSAcquisition of Phillips Aerospace
5th Sep 202312:04 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of Results
4th Sep 20231:20 pmRNSResult of General Meeting
25th Aug 20237:00 amRNSResult of Retail Offer
24th Aug 20233:07 pmRNSResult of AGM
16th Aug 20237:05 amRNSRetail Offer for up to £0.3 million
16th Aug 20237:00 amRNSProposed Acquisition and Notice of General Meeting
11th Aug 20233:15 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSNew Product Announcement
1st Aug 202310:58 amRNSNew Product Announcement
20th Jul 20237:00 amRNSNotification of Major Holdings
18th Jul 20237:00 amRNSPosting of Annual Report and Notice of AGM
17th Jul 20237:00 amRNSPost-Close Trading Update
30th Jun 20237:00 amRNSResults for the year ended 31 December 2022
19th Jun 20237:00 amRNSUpdate on Audited Annual Results
12th Jun 20237:00 amRNSSignificant Systems Win
9th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20237:00 amRNSNew Distributor Agreement
5th Jun 20237:00 amRNSNotice of Results
24th Mar 20237:00 amRNSNew Product Announcement
21st Mar 20237:00 amRNSReseller Agreement
4th Jan 20237:00 amRNSPost-Close Trading Update
14th Dec 20227:00 amRNSPartnership Agreement
28th Oct 20227:00 amRNSIssue of Share options and PDMR dealing
5th Oct 20227:00 amRNSConcurrent Technologies Enters the Systems Market
26th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Interim Results
24th Aug 202210:29 amRNSHolding(s) in Company
24th Aug 202210:27 amRNSHolding(s) in Company
19th Aug 202212:06 pmRNSHolding(s) in Company
13th Jul 20227:00 amRNSSupply Agreement
29th Jun 202212:55 pmRNSResult of AGM
30th May 20227:00 amRNSPosting of Annual Report & Notice of AGM
23rd May 20222:46 pmRNSIssue of Share options and PDMR dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.